Growth factors in chronic obstructive pulmonary disease

J. Sauleda, A. Noguera, D. Blanquer, A. Fuster, A. R. Pons, J. Pons, A. Agusti (Palma Mallorca, Spain)

Source: Annual Congress 2004 - A translational approach to mechanisms of lung disease
Session: A translational approach to mechanisms of lung disease
Session type: Thematic Poster Session
Number: 2040
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Sauleda, A. Noguera, D. Blanquer, A. Fuster, A. R. Pons, J. Pons, A. Agusti (Palma Mallorca, Spain). Growth factors in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: Suppl. 48, 2040

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Risk factors for chronic obstructive pulmonary disease in women
Source: Eur Respir J 2002; 20: Suppl. 38, 326s
Year: 2002

Comorbidities in the course of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Chronic obstructive pulmonary disease
Source: Eur Respir Mon; 2009: 45: 25–31
Year: 2009

Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2014; 65: 1-17
Year: 2014


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2015; 70: 80-98
Year: 2015


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2013; 62: 1-18
Year: 2013


Inflammation and depression in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 718s
Year: 2007

Anemia in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012

Genetic risks in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 454s
Year: 2003

Angiogenic status in patients with chronic obstructive pulmonary disease.
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Cardiovascular risk factors in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006

Erythropoietin dysregulation in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008


Determinants of depression at exacerbation in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007

Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006

Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003



Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012


Comorbidities in chronic obstructive pulmonary disease: Prognostic factors?
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019